Free Trial

Doximity (NASDAQ:DOCS) Director Sells $354,200.00 in Stock

Doximity logo with Medical background

Key Points

  • Doximity Director Regina Benjamin sold 5,000 shares of stock for $354,200, decreasing her total holdings by 20.13% to 19,839 shares valued at approximately $1.4 million.
  • Doximity's stock price has experienced fluctuations, closing at $67.06 recently, with a market capitalization of $12.56 billion and a P/E ratio of 67.06.
  • Analysts have mixed ratings on Doximity, with price targets ranging from $64.00 to $80.00, reflecting varying opinions on the company's market potential.
  • MarketBeat previews the top five stocks to own by November 1st.

Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Regina Benjamin sold 5,000 shares of the firm's stock in a transaction on Friday, October 10th. The stock was sold at an average price of $70.84, for a total value of $354,200.00. Following the transaction, the director directly owned 19,839 shares of the company's stock, valued at $1,405,394.76. The trade was a 20.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Doximity Price Performance

Doximity stock traded down $0.44 during mid-day trading on Tuesday, hitting $67.06. 1,323,074 shares of the company were exchanged, compared to its average volume of 2,138,071. The business's 50 day simple moving average is $68.65 and its two-hundred day simple moving average is $61.02. The company has a market capitalization of $12.56 billion, a P/E ratio of 67.06, a PEG ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 12-month low of $40.87 and a 12-month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current year.

Analyst Ratings Changes

DOCS has been the subject of a number of recent analyst reports. The Goldman Sachs Group set a $64.00 price objective on Doximity and gave the company a "sell" rating in a research report on Wednesday, October 1st. Robert W. Baird lifted their price objective on Doximity from $75.00 to $80.00 and gave the company an "outperform" rating in a research report on Thursday, September 11th. Zacks Research downgraded Doximity from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Bank of America lifted their price objective on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. Finally, Needham & Company LLC lifted their price objective on Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $69.37.

View Our Latest Report on Doximity

Institutional Investors Weigh In On Doximity

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Hantz Financial Services Inc. increased its stake in Doximity by 148.9% during the second quarter. Hantz Financial Services Inc. now owns 453 shares of the company's stock worth $28,000 after acquiring an additional 271 shares during the last quarter. VSM Wealth Advisory LLC acquired a new stake in Doximity during the first quarter worth about $29,000. Allworth Financial LP increased its stake in Doximity by 104.0% during the first quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after acquiring an additional 287 shares during the last quarter. National Bank of Canada FI acquired a new stake in Doximity during the first quarter worth about $33,000. Finally, Spire Wealth Management increased its stake in Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after acquiring an additional 260 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Insider Buying and Selling by Quarter for Doximity (NASDAQ:DOCS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.